Usage Information
Citation Information: J Clin Invest. 1974;53(5):1368-1374. https://doi.org/10.1172/JCI107685.
Abstract
The present studies were performed to determine whether dipeptide absorption in human jejunum exhibits the characteristics of carrier-mediated transport. 15-cm jejunal segments from human volunteers were perfused with test solutions containing varying amounts of either glycylglycine, glycylleucine, glycine, leucine, glycylglycine with leucine or glycine, glycylglycine with glycylleucine, or glycylleucine with an equimolar mixture of free glycine and leucine. Jejunal absorption rates of both glycylglycine and glycylleucine followed the kinetics of a saturable process. The Km value in millimoles/liter of glycylglycine was significantly greater than the Km value of glycylleucine (43.3±2.6 vs. 26.8±5.9, P < 0.05); and the Km value of glycine was also significantly greater than the Km value of leucine (42.7±7.5 vs. 20.4±5.4, P < 0.05). While overlapping occurred among the Km values of free amino acids and dipeptides, the transport kinetics of dipeptides were characterized by higher Vmax values (in micromoles per minute per 15 centimeters) than those of free amino acids. For example, the Vmax values for glycylglycine and glycine were 837±62 and 590±56, respectively (P < 0.02). While jejunal absorption rates of glycylglycine were not significantly affected by free leucine or free glycine, they were competitively inhibited by glycylleucine. The jejunal absorption rate of glycylleucine was not significantly altered by an equimolar mixture of free glycine and leucine. The selective absorption of dipeptides was investigated by infusing three equimolar mixtures, each containing two different dipeptides. Among the three dipeptides examined, glycylglycine was the least absorbed. There was no significant difference between the absorption of glycylleucine and leucylglycine.
Authors
Siamak A. Adibi, Mohammad R. Soleimanpour
Usage data is cumulative from July 2024 through July 2025.
| Usage | JCI | PMC |
|---|---|---|
| Text version | 175 | 17 |
| 61 | 11 | |
| Scanned page | 284 | 0 |
| Citation downloads | 61 | 0 |
| Totals | 581 | 28 |
| Total Views | 609 | |
Usage information is collected from two different sources: this site (JCI) and Pubmed Central (PMC). JCI information (compiled daily) shows human readership based on methods we employ to screen out robotic usage. PMC information (aggregated monthly) is also similarly screened of robotic usage.
Various methods are used to distinguish robotic usage. For example, Google automatically scans articles to add to its search index and identifies itself as robotic; other services might not clearly identify themselves as robotic, or they are new or unknown as robotic. Because this activity can be misinterpreted as human readership, data may be re-processed periodically to reflect an improved understanding of robotic activity. Because of these factors, readers should consider usage information illustrative but subject to change.
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)